000			02040 a2200589 4500
005			20250513234337.0
264		0	_c20010726
008			200107s 0 0 eng d
022			_a0014-2999
024	7		_a10.1016/s0014-2999(01)00862-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aLockhart, B
245	0	0	_aProtective effect of the antioxidant 6-ethoxy-2,2-pentamethylen-1,2-dihydroquinoline (S 33113) in models of cerebral neurodegeneration. _h[electronic resource]
260			_bEuropean journal of pharmacology _cMar 2001
300			_a59-68 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAlloxan _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aAntioxidants _xpharmacology
650	0	4	_aBody Temperature _xdrug effects
650	0	4	_aBrain Ischemia _xprevention & control
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCerebral Cortex _xdrug effects
650	0	4	_aCorpus Striatum _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aDopamine _xmetabolism
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aHippocampus _xcytology
650	0	4	_aHyperglycemia _xchemically induced
650	0	4	_aInjections, Intraventricular
650	0	4	_aKainic Acid _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMethamphetamine _xadministration & dosage
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMice, Inbred Strains
650	0	4	_aNerve Degeneration _xmortality
650	0	4	_aNeurons _xcytology
650	0	4	_aQuinolines _xpharmacology
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aRectum
650	0	4	_aSurvival Rate
650	0	4	_atert-Butylhydroperoxide _xpharmacology
700	1		_aBonhomme, N
700	1		_aRoger, A
700	1		_aDorey, G
700	1		_aCasara, P
700	1		_aLestage, P
773	0		_tEuropean journal of pharmacology _gvol. 416 _gno. 1-2 _gp. 59-68
856	4	0	_uhttps://doi.org/10.1016/s0014-2999(01)00862-7 _zAvailable from publisher's website
999			_c11217812 _d11217812